Erin G. Reid

Hematology

200 W Arbor Dr
San Diego, CA 92103

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Journal: Hematology/oncology clinics of North America

Published: September 02, 2026

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 09, 2025

Evaluating the impact of a year-long external mentorship pilot program in classical hematology.

Evaluating the impact of a year-long external mentorship pilot program in classical hematology.

Journal: Blood advances

Published: March 20, 2024

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Journal: Surgical oncology clinics of North America

Published: February 24, 2024

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 07, 2023

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: June 19, 2023

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2023

Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency.

Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency.

Journal: Blood advances

Published: January 25, 2023

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

Journal: The Lancet. Haematology

Published: January 24, 2023

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 15, 2021

Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.

Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.

Journal: AIDS research and human retroviruses

Published: September 29, 2021

The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy.

The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 21, 2021

Showing 1-12 of 51

Last Updated: 09/26/2026